Alcohol and Longevity: What the Evidence Actually Shows
For three decades, the J-curve hypothesis - that moderate alcohol consumption reduced cardiovascular mortality compared to abstinence - dominated public health messaging and gave millions of people permission to feel virtuous about their evening glass of wine. That hypothesis has since been substantially dismantled by Mendelian randomization studies and a re-analysis of the abstainer comparison group. The honest current evidence on alcohol and longevity is considerably less forgiving than the mainstream narrative.
- Much of the apparent heart benefit of moderate drinking came from comparing drinkers with 'abstainers' who included people who had cut down or quit because of illness; studies without this error found light or moderate drinkers and abstainers at equal risk.2
- In a genetic study of 371,463 UK Biobank participants, alcohol at all amounts was associated with higher cardiovascular risk, rising only slightly at light intake but sharply at heavier intake.3
- The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen, and the 2016 Global Burden of Disease analysis found that cancer risk rises with increasing consumption.4,7
- Alcohol helps people fall asleep but disrupts the second half of the night and, at moderate and higher doses, reduces REM sleep in most studies.5
- After correcting for these biases, a 2023 meta-analysis of 107 studies found that low-volume drinking was not linked to lower mortality, while risk rose at higher intakes, starting at lower levels for women than for men.6
The J-curve idea came from observational studies. A 2011 meta-analysis of 84 prospective studies found that drinkers had about 25% lower cardiovascular death rates than non-drinkers (relative risk 0.75).1 The finding influenced guidelines and public messaging, but it appears to have been largely an artefact of how non-drinkers were defined.
The Sick Quitter Problem
The key flaw was the abstainer group. People tend to cut down or stop drinking as they age, become ill or frail, or start new medications. If they are counted as abstainers, their poor health, not their abstinence, raises that group's risk. A meta-analysis found that the few studies that kept occasional and former drinkers out of the abstainer category showed abstainers and light or moderate drinkers at equal risk of death from all causes and from coronary heart disease.2
A larger 2023 meta-analysis of 107 cohort studies with 4.8 million participants reached the same conclusion. After adjusting for former-drinker bias and other quality problems, occasional drinkers (relative risk 0.96) and low-volume drinkers, up to about 24 g of alcohol a day (0.93), did not have significantly lower mortality than lifetime non-drinkers, while those drinking 45 g a day or more had significantly higher mortality, and risk rose at lower levels for women than for men.6
Mendelian Randomization: The More Rigorous Evidence
Mendelian randomization uses genetic variants that influence drinking as a natural experiment, avoiding much of the lifestyle confounding in observational studies. In UK Biobank, light to moderate drinkers had healthier lifestyles, and adjusting for those factors weakened the apparent heart benefit of modest drinking.3
In the genetic analyses of the same 371,463 participants, each standard deviation increase in genetically predicted alcohol intake was associated with 1.3 times the risk of high blood pressure and 1.4 times the risk of coronary artery disease. The increase in risk was minimal at light intake but exponential at heavier intake, and the authors concluded that alcohol consumption of all amounts was associated with increased cardiovascular risk.3
Cancer Risk: The Clearest Signal
The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen, causally linked to cancers of the mouth, throat, oesophagus, liver, bowel and female breast.4
The 2016 Global Burden of Disease analysis found that the risk of death from all causes, and of cancers specifically, rises with increasing consumption, and that the level of drinking that minimised harm across health outcomes was zero standard drinks per week.7 A 2022 update found that the picture varies with age: for people aged 15 to 39 the lowest-risk level was at or close to zero, whereas for people aged 40 and older the risk curve was J-shaped, with the lowest-risk level ranging from about 0.1 to 1.9 standard drinks a day depending on region.8
Sleep Disruption: An Underappreciated Harm
Alcohol's effect on sleep matters because many people drink to help them sleep. A review of all known studies in healthy volunteers found that, at all doses, alcohol shortens the time to fall asleep and consolidates the first half of sleep but increases disruption in the second half. It delays the first REM period at all doses and reduces total REM sleep in most studies at moderate and high doses, while increasing deep slow-wave sleep early in the night.5
In short, alcohol is a poor sleep aid: the quicker sleep onset is offset by disrupted sleep later in the night.
The best current evidence does not support drinking for health. Apparent benefits of moderate drinking were largely explained by biases in older studies, genetic evidence links alcohol to higher cardiovascular risk, cancer risk rises with consumption, and alcohol disrupts sleep. Global estimates suggest that risk varies with age, because the overall effect depends partly on background disease rates.8 If you do not drink, there is no health reason to start. If you do, less is better for health, and the enjoyment and social side of drinking are yours to weigh against an honest account of the risks.
Put this research into practice: Biomarker Reference Tool
References
- 1Ronksley PE, et al. "Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis." BMJ. 2011;342:d671. PubMed · DOI
- 2Fillmore KM, et al. "Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses." Ann Epidemiol. 2007;17(5 Suppl):S16-23. PubMed · DOI
- 3Biddinger KJ, et al. "Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease." JAMA Netw Open. 2022;5(3):e223849. PubMed · DOI
- 4IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. "Alcohol Consumption and Ethyl Carbamate." IARC Monographs. 2010;96:1-1426.
- 5Ebrahim IO, et al. "Alcohol and sleep I: effects on normal sleep." Alcohol Clin Exp Res. 2013;37(4):539-49. PubMed · DOI
- 6Zhao J, et al. "Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses." JAMA Netw Open. 2023;6(3):e236185. PubMed · DOI
- 7GBD 2016 Alcohol Collaborators. "Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016." Lancet. 2018;392(10152):1015-1035. PubMed · DOI
- 8GBD 2020 Alcohol Collaborators. "Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020." Lancet. 2022;400(10347):185-235. PubMed · DOI
